MiNK Therapeutics, Inc. (NASDAQ:INKT) Q4 2024 Earnings Conference Call March 18, 2025 8:30 AM ET Company Participants Zack Armen - Investor Relations Dr. Jennifer Buell - President and CEO Christine Klaskin - Principal Financial and Accounting Officer Conference Call Participants Emily Bodnar - H.C. Wainwright Mayank Mamtani - B. Riley Securities Jack Allen - Baird Operator Hello, everyone. And welcome to MiNK Therapeutics Fourth Quarter 2024 Financial Results Call. Please note that this call is being recor ...